News

Acerus Pharmaceuticals Corporation announced that Hyundai Pharm Co., Ltd. (Hyundai), Acerus’ licensee, reported that South Korea’s Ministry of Food and Drug Safety (MFDS) has approved…
Read More...

STA Pharmaceutical, a subsidiary of WuXi AppTec, congratulates its partner Ascletis for receiving approval from National Drug Administration of China (CNDA, former CFDA) of its Category…
Read More...

Prana Biotechnology received ethics committee approval and has commenced recruitment for its Phase I Clinical trial evaluating the safety, tolerability and pharmacokinetics of the…
Read More...

Catalent Pharma Solutions announced that it has appointed Mr. Paul Hegwood as President of the company’s Clinical Supply Services business. He succeeds Mr. Wetteny Joseph, who was named…
Read More...

Alcami Corporation announced the expanded deployment of its Extended Workbench laboratory services program to support the ongoing manufacturing and development of ZILRETTA…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the United Kingdom’s National Institute for Health and Care Excellence (NICE) has published positive…
Read More...

Cambrex Corporation announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy. The investment will be in the construction of a new 150m²…
Read More...

AbCellera Biologics announced the successful completion of the first phase of its collaboration with Denali Therapeutics. Under the collaboration, AbCellera applied its single-cell…
Read More...

Asterias Biotherapeutics announced enrollment and dosing of the first subject in the first-in-human Phase 1 clinical trial of AST-VAC2 in the United Kingdom. This initial clinical…
Read More...

Eisai Inc. announced it will launch the Eisai Center for Genetics Guided Dementia Discovery, which will harness the power of human genetics to develop next-generation medicines for…
Read More...

Nordic Nanovector ASA announces that the US Food & Drug Administration (FDA) has granted Fast Track designation to Betalutin (177Lu-lilotomab satetraxetan) for the treatment of…
Read More...

LabCorp announced that it has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and…
Read More...

ICON plc announced it has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality, for…
Read More...

Alexion Pharmaceuticals and Complement Pharma announced a partnership to co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders. C6 inhibition prevents…
Read More...

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life, has secured a…
Read More...

Translate Bio announced a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to…
Read More...

BioMarin Pharmaceutical Inc. announced that the Company received $20 million in milestone payments from Pfizer Inc. These milestone payments were triggered by the U.S. Food and Drug…
Read More...

Microbiotica announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialise biomarkers,…
Read More...

Thermo Fisher Scientific Inc. officially opened its U.S. Precision Medicine Science Center (PMSC) in Cambridge, Mass. The Center offers access to advanced "omics" technologies and…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) has approved Rituxan (rituximab) for the treatment of adults with moderate to severe pemphigus vulgaris (PV), a…
Read More...